Neurology20121433蛋白诊断CJD准确性.pdfVIP

Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease : Report of the Guideline Development Subcommittee of the American Academy of Neurology Taim Muayqil, Gary Gronseth and Richard Camicioli Neurology ; Published online before print September 19, 2012; DOI 10.1212/WNL.0b013e31826d5fc3 This information is current as of September 23, 2012 The online version of this article, along with updated information and services, is located on the World Wide Web at: /content/early/2012/09/19/WNL.0b013e31826d5fc3 Neurology ® is the official journal of the American Academy of Neurology. Published continuously since 1951, it is now a weekly with 48 issues per year. Copyright © 2012 by AAN Enterprises, Inc. All rights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X. Published Ahead of Print on September 19, 2012 as 10.1212/WNL.0b013e31826d5fc3 SPECIAL ARTICLE Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease Report of the Guideline Development Subcommittee of the American Academy of Neurology Taim Muayqil, MBBS, ABSTRACT FRCPC Objective: To assess the available evidence for the diagnostic accuracy of CSF testing for protein Gary Gronseth, MD, 14-3-3 in patients with suspected sporadic Creutzfeldt-Jakob disease (sCJD). FAAN